Veterinary Medicines

AviPro GUMBORO VAC Lyophilisate for suspension for chicken

Authorised
  • Infectious bursal disease virus, strain Cu-1 M, Live
Download as PDF

Product identification

Medicine name:
AviPro GUMBORO VAC Lyophilisate for suspension for chicken
AviPro GUMBORO VAC
Active substance:
  • Infectious bursal disease virus, strain Cu-1 M, Live
Target species:
  • Chicken (broiler)
  • Chicken
  • Chicken (for reproduction)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain Cu-1 M, Live
    5011.87
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (broiler)
      • Meat and offal
        0
        day
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • (ID1): 1 Box with 1 Bottle (Glass) with 1000 Dose (1000 Dose)
  • (ID4): 1 Box with 10 Bottle (Glass) with 2500 Dose (25000 Dose)
  • (ID2): 1 Box with 10 Bottle (Glass) with 1000 Dose (10000 Dose)
  • (ID3): 1 Box with 1 Bottle (Glass) with 2500 Dose (2500 Dose)
  • (ID7): 1 Box with 1 Bottle (Glass) with 10000 Dose (10000 Dose)
  • (ID8): 1 Box with 10 Bottle (Glass) with 10000 Dose (100000 Dose)
  • (ID6): 1 Box with 10 Bottle (Glass) with 5000 Dose (50000 Dose)
  • (ID5): 1 Box with 1 Bottle (Glass) with 5000 Dose (5000 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lohmann Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Animal Health GmbH
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 87a/78
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0206/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Greece
  • Lithuania
  • Netherlands
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
German (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."